8-67952493-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BA1
The NM_024870.4(PREX2):c.99G>A(p.Lys33Lys) variant causes a synonymous change. The variant allele was found at a frequency of 0.308 in 1,607,296 control chromosomes in the GnomAD database, including 80,095 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.25 ( 5726 hom., cov: 32)
Exomes 𝑓: 0.31 ( 74369 hom. )
Consequence
PREX2
NM_024870.4 synonymous
NM_024870.4 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 6.00
Genes affected
PREX2 (HGNC:22950): (phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2) The protein encoded by this gene belongs to the phosphatidylinositol 3,4,5-trisphosphate (PIP3)-dependent Rac exchanger (PREX) family, which are Dbl-type guanine-nucleotide exchange factors for Rac family small G proteins. Structural domains of this protein include the catalytic diffuse B-cell lymphoma homology and pleckstrin homology (DHPH) domain, two disheveled, EGL-10, and pleckstrin homology (DEP) domains, two PDZ domains, and a C-terminal inositol polyphosphate-4 phosphatase (IP4P) domain that is found in one of the isoforms. This protein facilitates the exchange of GDP for GTP on Rac1, allowing the GTP-bound Rac1 to activate downstream effectors. Studies also show that the pleckstrin homology domain of this protein interacts with the phosphatase and tensin homolog (PTEN) gene product to inhibit PTEN phosphatase activity, thus activating the phosphoinositide-3 kinase (PI3K) signaling pathway. Conversely, the PTEN gene product has also been shown to inhibit the GEF activity of this protein. This gene plays a role in insulin-signaling pathways, and either mutations or overexpression of this gene have been observed in some cancers. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 8-67952493-G-A is Benign according to our data. Variant chr8-67952493-G-A is described in ClinVar as [Benign]. Clinvar id is 3060181.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.506 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PREX2 | NM_024870.4 | c.99G>A | p.Lys33Lys | synonymous_variant | 1/40 | ENST00000288368.5 | NP_079146.2 | |
PREX2 | NM_025170.6 | c.99G>A | p.Lys33Lys | synonymous_variant | 1/24 | NP_079446.3 | ||
PREX2 | XM_047422268.1 | c.99G>A | p.Lys33Lys | synonymous_variant | 1/28 | XP_047278224.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PREX2 | ENST00000288368.5 | c.99G>A | p.Lys33Lys | synonymous_variant | 1/40 | 1 | NM_024870.4 | ENSP00000288368.4 | ||
PREX2 | ENST00000529398.5 | n.126G>A | non_coding_transcript_exon_variant | 1/24 | 1 | |||||
PREX2 | ENST00000517617.1 | n.5G>A | non_coding_transcript_exon_variant | 1/24 | 2 |
Frequencies
GnomAD3 genomes AF: 0.251 AC: 38125AN: 151932Hom.: 5732 Cov.: 32
GnomAD3 genomes
AF:
AC:
38125
AN:
151932
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.314 AC: 73677AN: 234986Hom.: 12430 AF XY: 0.317 AC XY: 40544AN XY: 127760
GnomAD3 exomes
AF:
AC:
73677
AN:
234986
Hom.:
AF XY:
AC XY:
40544
AN XY:
127760
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.314 AC: 456289AN: 1455248Hom.: 74369 Cov.: 37 AF XY: 0.316 AC XY: 228375AN XY: 723482
GnomAD4 exome
AF:
AC:
456289
AN:
1455248
Hom.:
Cov.:
37
AF XY:
AC XY:
228375
AN XY:
723482
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.251 AC: 38122AN: 152048Hom.: 5726 Cov.: 32 AF XY: 0.253 AC XY: 18806AN XY: 74328
GnomAD4 genome
AF:
AC:
38122
AN:
152048
Hom.:
Cov.:
32
AF XY:
AC XY:
18806
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1379
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PREX2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at